Document Detail


Single dose of glutamine enhances myocardial tissue metabolism, glutathione content, and improves myocardial function after ischemia-reperfusion injury.
MedLine Citation:
PMID:  14621120     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Myocardial ischemia and reperfusion (I/R) injury causes significant morbidity and mortality. Protection against I/R injury may occur via preservation of tissue metabolism and ATP content, preservation of reduced glutathione, and stimulation of heat shock protein (HSP) synthesis. Supplementation with glutamine (GLN) has been reported to have beneficial effects on all of these protective pathways. Thus, we hypothesized that GLN pretreatment given to the rat in vivo would protect the myocardium against I/R-induced dysfunction. METHODS: GLN (0.52 g/kg, intraperitoneally, given as alanine-glutamine dipeptide), alanine alone (0.23 g/kg), or a Ringer's lactate solution (control) was administered to Sprague-Dawley rats 18 hours before heart excision, perfusion, exposure to global ischemia (15 minutes) and reperfusion (1 hour). Tissue metabolites were analyzed via magnetic resonance spectroscopy. RESULTS: In control and alanine-treated animals, I/R injury resulted in cardiac dysfunction, indicated by a decrease in cardiac output. Administration of GLN 18 hours before I/R injury preserved cardiac output after reperfusion. Metabolic analysis of the myocardial tissue revealed that [/R injury led to significant diminution of myocardial tissue glutamate, ATP content, accumulation of myocardial lactate, and a reduction in reduced glutathione content in control animals. GLN significantly reduced the deleterious changes in myocardial metabolism and improved reduced glutathione content. No changes in pre- or post-I/R injury HSP expression were observed after GLN administration. CONCLUSIONS: These observations demonstrate that remote in vivo administration of GLN before cardiac I/R injury can improve post-I/R cardiac function. This effect may be mediated via improved myocardial metabolism and enhanced reduced glutathione content.
Authors:
Paul E Wischmeyer; David Jayakar; Ursula Williams; Kristen D Singleton; Jacob Riehm; Emile A Bacha; Valluvan Jeevanandam; Uwe Christians; Natalie Serkova
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  JPEN. Journal of parenteral and enteral nutrition     Volume:  27     ISSN:  0148-6071     ISO Abbreviation:  JPEN J Parenter Enteral Nutr     Publication Date:    2003 Nov-Dec
Date Detail:
Created Date:  2003-11-17     Completed Date:  2004-04-27     Revised Date:  2007-02-21    
Medline Journal Info:
Nlm Unique ID:  7804134     Medline TA:  JPEN J Parenter Enteral Nutr     Country:  United States    
Other Details:
Languages:  eng     Pagination:  396-403     Citation Subset:  IM    
Affiliation:
Department of Anesthesiology, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA. paul.wischmeyer@UCHSC.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenosine Diphosphate / analysis
Adenosine Triphosphate / analysis
Alanine / administration & dosage
Animals
Cardiac Output / drug effects,  physiology
Coronary Circulation / drug effects,  physiology
Disease Models, Animal
Dose-Response Relationship, Drug
Glucose / analysis
Glutamine / administration & dosage*
Glutathione / drug effects*,  metabolism*
HSP72 Heat-Shock Proteins
Heart / drug effects*,  physiology
Heart Rate / drug effects,  physiology
Heat-Shock Proteins / biosynthesis,  drug effects
Injections, Intravenous
Lactic Acid / metabolism
Male
Models, Cardiovascular
Myocardial Reperfusion Injury / metabolism*,  physiopathology*
Myocardium / chemistry,  metabolism*
NAD / drug effects,  metabolism
Rats
Rats, Sprague-Dawley
Time Factors
Chemical
Reg. No./Substance:
0/HSP72 Heat-Shock Proteins; 0/Heat-Shock Proteins; 50-21-5/Lactic Acid; 50-99-7/Glucose; 53-84-9/NAD; 56-41-7/Alanine; 56-65-5/Adenosine Triphosphate; 56-85-9/Glutamine; 58-64-0/Adenosine Diphosphate; 70-18-8/Glutathione

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Improving nutritional screening of hospitalized patients: the role of prealbumin.
Next Document:  Oral glutamine (AES-14) supplementation inhibits PI-3k/Akt signaling in experimental breast cancer.